Correlation Between INmune Bio and Landos Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both INmune Bio and Landos Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INmune Bio and Landos Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INmune Bio and Landos Biopharma, you can compare the effects of market volatilities on INmune Bio and Landos Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INmune Bio with a short position of Landos Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of INmune Bio and Landos Biopharma.

Diversification Opportunities for INmune Bio and Landos Biopharma

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between INmune and Landos is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and Landos Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Landos Biopharma and INmune Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INmune Bio are associated (or correlated) with Landos Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Landos Biopharma has no effect on the direction of INmune Bio i.e., INmune Bio and Landos Biopharma go up and down completely randomly.

Pair Corralation between INmune Bio and Landos Biopharma

Given the investment horizon of 90 days INmune Bio is expected to generate 15.98 times less return on investment than Landos Biopharma. But when comparing it to its historical volatility, INmune Bio is 1.74 times less risky than Landos Biopharma. It trades about 0.01 of its potential returns per unit of risk. Landos Biopharma is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  231.00  in Landos Biopharma on August 29, 2024 and sell it today you would earn a total of  171.00  from holding Landos Biopharma or generate 74.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy31.45%
ValuesDaily Returns

INmune Bio  vs.  Landos Biopharma

 Performance 
       Timeline  
INmune Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days INmune Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Landos Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Landos Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Landos Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

INmune Bio and Landos Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with INmune Bio and Landos Biopharma

The main advantage of trading using opposite INmune Bio and Landos Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INmune Bio position performs unexpectedly, Landos Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Landos Biopharma will offset losses from the drop in Landos Biopharma's long position.
The idea behind INmune Bio and Landos Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamental Analysis
View fundamental data based on most recent published financial statements